As a novel endocrine factor, circulating Nrg4 may activate the receptor kinases ErbB3 and ErbB4 and coordinate glucose and lipid homeostasis in obesity [12, 35]. The gene discussed is ERBB3; the disease is obesity due to melanocortin 4 receptor deficiency.